-
Loading metrics
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach
- Xiaoyan Li,
- Allison Keshishian,
- Melissa Hamilton,
- Ruslan Horblyuk,
- Kiran Gupta,
- Xuemei Luo,
- Jack Mardekian,
- Keith Friend,
- Anagha Nadkarni,
- Xianying Pan
x
- Published: January 26, 2018
- https://doi.org/10.1371/journal.pone.0191722